Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A clinical trial of TCR-modified T cells.

Trial Profile

A clinical trial of TCR-modified T cells.

Phase of Trial: Phase I

Latest Information Update: 27 Mar 2017

At a glance

  • Drugs TCR-transduced lymphocytes (Primary)
  • Indications Autoimmune disorders; T-cell leukaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Mar 2017 New trial record
    • 23 Mar 2017 According to a Medigene AG media release, complany plans to initiate this trial in second half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top